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Introduction: The frequency of the metabolic syndrome is increasing throughout 
the world. The etiology of the metabolic syndrome is dependent on different 
factors. This study aimed to evaluate the metabolic syndrome among Sistanee 
ethnic women in Gorgan, North East of Iran.  
Methods: The study conducted on the hundred and sixty Sistanee women (20-
40years) who were referred to the Health Centers in Gorgan. Metabolic syndrome 
was diagnosed using Adult Treatment Panel-III (ATP-III) guidelines.  
Results: The mean body mass index, waist circumference, systolic blood pressure, 
diastolic blood pressure, fasting blood glucose and levels were significantly 
higher in the subjects with metabolic syndrome. The prevalence of low High 
Density Lipoprotein-cholesterol level, high waist circumference, high triglyceride 
level, , high blood pressure and high fasting glucose were 23.12%, 22.50%, 
16.25%, 12.50% and 0.62%, respectively. Low HDL-cholesterol level (23.12%) 
and high waist circumference (22.50%) are the most frequent characteristics in 
comparison to other metabolic components.  
Conclusion: The reasonable interpretation for our results is that Sistanee women 
in this area maybe had lower physical activity. Low HDL-cholesterol and high  
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waist circumference were the most usual factors of metabolic abnormality among 
these women. 
 





The metabolic syndrome is described by the clustering of several risk factors for 
cardiovascular disease (CVD) such as central obesity, glucose intolerance, low 
level of high-density lipoprotein (HDL), high triglyceride (TG) level, and 
hypertension (1).There are ethnic differences in the prevalence of metabolic 
syndrome (2-4). Differences in genetic background, diet, levels of physical 
activity, age and sex structure all influence the prevalence of both metabolic 
syndrome and its components (5). The prevalence of metabolic syndrome in adult 
population worldwide varies from 8 to 24.2% (6-7) in males and from 7 to 46.5% 
(8-9) in females. Cardiovascular disease is one of the main reasons of death 
among women in the world (10). The importance of the metabolic syndrome in 
general populations as a predictor of vascular disease has been confirmed by a 
number of large prospective epidemiologic studies (11-13). In the United States, 
the metabolic syndrome has become common (7). The metabolic syndrome is an 
important public health problem in both developed and developing countries. The 
prevalence of metabolic syndrome in Europe and among Americans of European 
ethnic groups change approximately between 20% and 30%, in both gender (2, 5, 
7 and 14-15). Some studies show about increasing prevalence of metabolic 
syndrome in Asia (16). In our area, we do not have enough data on the adult 
Sistanee ethnic group women metabolic syndrome in Gorgan (South East of 
Caspian Sea), Iran. Therefore, it is very important to set up a study on these 
women with a risk of metabolic syndrome. The present study aimed to assess the 





This study group included 160 Sistanee adult women (Women who speak sistanee 
language which is native to them) who were referred to the different Health 
Centers in Gorgan. All the included subjects provided an informed consent. Data 
were collected by trained interviewers. First of all, a questionnaire was completed 
at each Health Center by trained interviewers. Demographic information is 
achieved by a questionnaire. The exclusion criterion was the coexistence of any 
other serious illness. Exclusion criteria included having hormone replacement 
therapy, taking drugs such as anti-diabetes and anti-hypertensive anti-lipidemic 
agents and smokers. A venous blood sample was collected from all the subjects 
who came after 8-12-hours in the morning after an overnight fast. The samples  
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were centrifuged for 10 minutes at 3000 rpm. The serum was used for estimating 
fasting blood glucose, triglycerides, total cholesterol, LDL-cholesterol and HDL-
cholesterol concentrations, by biochemical kit using spectrophotometer techniques 
(Model JENWAY 6105 UV / VIS) in the Biochemistry Research Center (Gorgan 
Faculty of Medicine). Adult women considered to have metabolic syndrome if 
they had any three or more of the following, according to the ATP III Criteria: [1] 
A) Abdominal obesity: Waist Circumference >88 cm  
B) Hypertriglyceridaemia: serum triglycerides level > 150 mg/dl 
C) Low HDL-cholesterol: < 50 mg/dl 
D) High blood pressure: SBP > 130 mmHg and/or DBP > 85 mmHg or on 
treatment for hypertension. 
E) High fasting glucose: serum glucose level > 110 mg/dl or on treatment for 
diabetes. 
Weight was then measured, while subjects were minimally clothed without shoes, 
using digital scales. Height was measured in standing position using tape meter 
while the shoulder was in a normal position. Body mass index (BMI) was 
calculated as weight in kilograms divided by height in meters squared. Those with 
a BMI of 25.0-29.9 Kg/m2 were classified as overweight, whilst those with a BMI 
≥30 Kg/m2 were defined as obese. Subjects with BMI greater than 45 Kg/m2 
were considered very obese (17). Waist circumference was measured at the point 
halfway between the lower border of ribs and the iliac crest in a horizontal plane 
(18). Systolic and diastolic blood pressure was measured in sitting position from 
the right hand. The results were reported as percentages and mean ± SD. The 
statistical analysis was done with SPSS- 16 version software. The results were 
evaluated by using independent student t and Chi square tests.  Statistical 





The baseline data of the subjects with and without the metabolic syndrome are 
shown in table 1. The mean body mass index, waist circumference, systolic blood 
pressure, diastolic blood pressure, fasting blood glucose and levels were 
significantly higher in the subjects with metabolic syndrome. There were no 
significant differences in the other parameters in subjects with and without the 
metabolic syndrome. Prevalence of metabolic syndrome and the components of 
metabolic syndrome in Sistanee ethnic group are shown in table 2. The frequency 
of metabolic syndrome is shown 23.75%. The prevalence of low High Density 
Lipoprotein-cholesterol level, high waist circumference, high triglyceride level, , 
high blood pressure and high fasting glucose were 23.12%, 22.50%, 16.25%, 
12.50% and 0.62%, respectively. Low HDL-cholesterol level (23.12%) and high 
waist circumference (22.50%) are the most frequent characteristics in comparison 
to other metabolic components. The prevalence of Sistanee women with and 
without metabolic syndrome by age group is shown in table 3. The most age  




distribution was in ages between 35-40 years. The highest prevalence of metabolic 
syndrome was in ages 35-40 years. There was increased frequency of metabolic 
syndrome from age 20-24 years. The prevalence of metabolic syndrome was 
significantly high in ages 30-34 years (21.05%) when compared subjects with and 
without metabolic syndrome. A number of subjects accomplishing the criteria of 
metabolic syndrome is shown in table 4. Our results showed that 18.12%, 6.87% 




Table 1 Baseline data of Fars women (Total subjects, subjects with and 




BMI: Body mass index, WC: waist circumference, SBP: systolic blood 
pressure, DBP: diastolic blood pressure, FBS: fasting blood glucose, TG: 
triglyceride, T-CHOL: total cholesterol, HDL-CHOL: HDL-cholesterol and 
LDL-CHOL: LDL-cholesterol 


















All women, No. 
(%) 
160 (100) 38 (23.75) 122(76.25) - 
Age (years) 30.71±6.80 32.50±6.41 30.11±6.80 0.058 
BMI, kg/m 2 26.26±3.98 27.92±4.46 25.76±3.71 0.003 
WC, cm 93.51±14.93 100.84±14.17 91.23±14.47 0.001 
SBP, mmHg 109.96±19.54 120.76±25.95 106.60±15.74 0.003 
DBP, mmHg 67.52±11.98 74.05±13.20 65.49±10.85 0..001 
FBS, mg/dl 91.40±26.75 114.35±41.16 84.26±14.34 <0.001 
TG,  mg/dl 112.44±73.85 159.05±88.21 97.91±62.35 <0.001 
T-Chol, mg/dl 187.54±45.54 204.68±70.56 182.20±33.29 0.064 
HDL-Chol , 
mg/dl 
40.95±8.94 40.37±6.22 41.13±9.64 0.646 
LDL-Chol , 
mg/dl 
126.49±36.92 131.64±55.55 124.88±28.92 0.325 





Table 2 Prevalence of metabolic syndrome and the components of metabolic 






















Age groups in 
years 
13 (10.65)  3 (7.89)  20-24 n (%)  
17 (13.93)  4 (10.52) 25-29 n (%) 
13(10.65) 8 (21.05)* 30-34 n (%) 
79 (64.75) 23(60.52) 35-40 n (%) 
MS: Metabolic Syndrome  
      *P value less than 0.05 was considered significant. 
 
 
Table 4.Number of subjects accomplishing the criteria of metabolic 
syndrome  
subjects(n=160) Parameters 
29 (18.12) 3 criteria n (%) 
11(6.87) 4 criteria n (%) 
3(1.87) 5 criteria n (%) 





The frequency of the metabolic syndrome is increasing throughout the world. The 
etiology of the metabolic syndrome is dependent on different factors such as the 




metabolic syndrome 38 23.75 
Fasting Blood Sugar >110 mg/dl 20 12.50 
High Density Lipoprotein-cholesterol 
< 50 mg/dl 
37 23.12 
Triglyceride > 150  mg/dl 26 16.25 
Waist  circumference > 88 cm 36 22.50 
Systolic blood pressure >130 mmHg/ 
Diastolic blood pressure>85 mmHg 
1 0.62 
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resistance, sociological and environmental, genetic factors and life style. The 
results of study in Asian people showed these risk factors and its high frequency 
might start at a young age. The epidemic of metabolic syndrome is worldwide 
health problem. It is not the only problem of western or Asian countries. Study in 
Italy showed that a prevalence of metabolic syndrome was 3–3.5% (on the basis 
of the presence of all five criteria)(20). Studies among Korean and Chinese 
populations showed that prevalence of metabolic syndrome were 13.8% (21) and 
17.8% for females, respectively (22). In Iran, Eshtiaghi et al. showed that 
prevalence of metabolic syndrome was 18.3% (23). Deilbert (24), Figueiredo 
Neto (25) is shown that prevalence of metabolic syndrome was 23% and 24%, 
respectively. In our study the prevalence of the metabolic syndrome is higher than 
some other studies were done in Italy, Korea, China, Iran [20-23], Deilbert (24) and 
Figueiredo Neto (25), but our study is not in agreement with the studies were done 
by Ainy (53%) (26) and Heidari et al (44.9%) (27). Studies in Greece and USA 
have shown that prevalence of metabolic syndrome was similar in both genders 
(28, 9). Some other studies in Turkey, India, Iran, African Americans, Mexican 
Americans have shown that women to be much more frequently affected (9, 29), 
while in France and Australia the metabolic syndrome was found to be more 
common among men (29). Study on the components of metabolic syndrome 
showed that the most frequent changes of components of metabolic syndrome was 
low High Density Lipoprotein-cholesterol (23.12%), which is in agreement with 
the findings in USA (30), Turkey (31), Italy (32), Canada (33), UK (34) and 
Iranian population (35-36) that the most common found was high prevalence of 
low HDL-cholesterol. Some studies have reported that waist circumference is 
positively associated with the risk of cardiovascular occurrences (37-38). Study of 
Despres et al showed that extra fat mass rather than excess body weight was 
highly correlated with abnormal metabolism (39). Our study showed that women 
with metabolic syndrome had high abdominal obesity. This study showed that 
waist circumference was elevated among Sistanee women with metabolic 
syndrome. It was been also shown that women were overweight. Changes in 
central obesity can cause metabolism abnormality and influence health (40). It is 
important to reduce the risk of cardiovascular disease among these women. It 
suggests that among women with metabolic syndrome, blood glucose, and blood 
lipid profile monitoring and changing their life style leading to weight loss by diet 
and sport (25). Despite lifestyle changes such as an increase in high-fat, high-
carbohydrate intake and a decrease in physical activity due to economical 
alterations in Iran, the metabolic syndrome in women remain an important 
problem. Study has been shown that 76.3% of females in Iran had physical 
inactivity (41). Iranian women mostly do less physical activity and overweight 
and obesity are more common between them (42). The reasonable interpretation 
for our results is that Sistanee women in this area maybe had lower physical 
activity. Low HDL-cholesterol and high waist circumference were the most usual 
factors of metabolic abnormality among these women. Prevalence of 
cardiovascular diseases might be increased. We have shown some related factors  
 




of metabolic syndrome in these women to predict metabolic syndrome in these 
ethnic groups and help to prevent cardiovascular disease. 
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